Hi all,
I’m having difficulty with this and need help. Here’s the Instructions and Prompt below:
“Instructions-
Projects that start with effective planning have a better chance of finishing strong. The creation of a good project charter will help the team coalesce around clarified objectives and will help guide the team to a successful conclusion.
In Module One, you wrote an overview of the case study you will be using for your final project. Your next step in this milestone will be to create a project charter continuing with the same case study.
To complete this assignment, review the Milestone One Guidelines and Rubric document, where you will find links to the case study, a case study data set, and a project charter template for your use.”
**Prompt:
” Prompt: In Module One, you wrote an overview of the case study you will be using for your final project. In this milestone, using the project charter template provided, you will now dig more deeply into the case study information to create a project charter, which gives you a high-level perspective of the project. A data set for this case study has also been provided for your benefit. You are expected to complete each section of the charter template. When you complete your final project program report, you will pull the information you need from your charter to complete your program report. For the project charter, specifically, the following critical elements must be addressed: I. Discuss the project purpose and background. Here you will provide the organization’s justification for taking on the project. II. Identify the project’s goals, objectives, and expectations. Be sure that your goals are measurable. III. Discuss the end product or service to be supplied. Here you will discuss the scope of the end product or service and the business need that the project will address. IV. Identify milestones/estimated deliverables. Note the relationship between the project deliverables and the project objectives. The deliverables should meet the objectives. V. Discuss the success criteria. How will “success” be measured? VI. Identify the high-level risks. How do the risks potentially impact the project? VII. Identify the key stakeholders. What is the role of each stakeholder in the project? VIII. Identify any assumptions, restrictions, and external dependencies. What are the assumptions on which decisions are being made? IX. Identify any customer responsibilities. Will the customer be doing any tasks or contributing any resources to the project? X. Complete a project category table allowing a high-level view of the project. XI. Specify a high-level budget.”
I need help with both parts: the charter and the data set. I’ll attach the template for the charter, the data set and module 1’s paper for extra guidance.
Thanks so much for your help; please reach out if you need any other documents/guidance.
Module 1-2: Case Study Overview
Objectives
This case study supplies an overview of the objectives and intended outputs of portfolio management and the reasons many firms utilize this approach in order to achieve their intended initiatives.
Specifically, regarding research and development firms, they craft their strategic plans in order to align to the firm’s overall target operating model, as well as the company’s overall mission; they are typically broken down into projects which are compiled into the main portfolio. In pharmaceutical firms, these goals typically include:
· Lowering drug expenses for the targeted client base
· Identifying opportunities in a given market to fill “gaps” where there is demand, but not supply (i.e.: new products, services, etc.)
· Increasing production in terms of efficiency, process improvement and upgrade research approaches.
In this case study specifically, the main goal is the first: lower costs. Therefore, the portfolio will ultimately be set up to achieve this intended objective. The other objectives will fall underneath as a sort of “umbrella.” That being the case, only projects which support this effort will be included in the firm’s portfolio, (Bode-Greuel, 2008).
Target Stakeholder Group
In this particular instance, the stakeholders would include the company’s client base. As the R&D firm’s main intent is to perform effectual research to develop new drugs which would support efforts to lower the firm’s overall drug costs, it stands to reason those purchasing the products and benefiting from the updated pricing would be the primary stakeholder group, (Bode-Greuel, 2008).
However, alongside the primary stakeholders will typically be other, indirect stakeholders. In this case study, examples would include partner companies who sell these products on behalf of the main company, and perhaps any adjoining supplier chain entities, as these companies would be also paying their own business costs and in that same vein, health insurance firms who cover all or part of the customer’s drug expenses would have a vested interest in this cost-reduction effort.
Taking this back to portfolio management, it would prove beneficial to these varying stakeholder groups as it will initiate an effort (or series of efforts), which will drive the pharmaceutical company’s investment in developing more price-friendly drugs. This portfolio of projects will all drive this output, but they won’t be approved by the sponsors until they demonstrate alignment to the corporate group’s overarching strategic goals.
The process which governs portfolio management will cover comprehension of diseases which will have many sub-segments. These would address overall disease comprehension and research, patient medical needs regarding the said disease, as well as other factors (like short vs long-term care) which will empower the firm to make an informed choice to invest in this venture or not, (2008).
In order to efficiently oversee a portfolio, the PM must closely monitor it through all phases of the lifecycle: initiation and planning to execution. Portfolios managed in a proficient manner will help secure the desired outputs, stay within scope and budget, within timetables set by leaders and obtain the ROI (return on investment) that is sought after by both internal and external stakeholders, as well as indirect stakeholders too.
These goals can be attained via any number of venues. They may include refining the process to be more efficient when creating new drugs. Also, upping productivity with the overall drug development process; focusing effort into crafting more streamlined research methods for new drugs and potential areas of interest which would benefit the firm’s operating model in multiple spaces, then highlight the ones that appear most promising. Key decision-makers and sponsors can leverage this information to call out the projects which appear to hold the most promise in terms of value, (2008).
Project, Portfolio & Program Levels
When a firm is rolling out a strategic initiative, it is typically broken down into three levels: project management, which are compiled into a program. The Programs in question are aligned to a Portfolio. Managers maintain direction and oversight at each level: project, portfolio, and program.
Project management is the leadership governance of a time-limited effort which includes a designated start and end period, along with a defined deliverable, which is a new product/service/etc. Well-vetted projects include a clearly defined output, including adequate descriptive details; also, there will usually be cross-functional leveraging and interdisciplinary partnerships (subject-matter-experts/SME’s). The project will have a defined schedule/timetable with an assumed consistent unrolling, a financial budget with constraints and a “safe margin” for unexpected costs. Finally, there will be a designated team, reserved tools, resources, and other assets, as well as leadership governance and reporting/fiscal updating expectations. Each project will include the in proposal how it aligns to the firm’s corporate approach.
Projects are grouped into Programs. Like projects, there are managers, but as each project is aligned to a similar Program, the program manager will have an oversight of several complimentary projects in-flight at one time. Using this approach helps to optimize the beneficial outputs of each project that may not be so assured if each were executed alone.
Lastly, Programs are compiled into Portfolios.
Corporate Strategy Alignment
The drive acting as an undercurrent for these projects (and the full portfolio) is adding value. The corporate strategy the firm has adopted is to lower costs, increase efficiency and streamline the process to lower overall company expenses whilst increasing production processes. The methodology selected to choose which projects will be compiled into the portfolio will also be utilized by the project teams to ensure continued alignment with the firm’s strategy and intended goals, also while remaining aligned to the expectations set forth by internal and external stakeholders.
Project Manager’s Role
For the PM, their role is to facilitate the project selection process, to ensure value is present in each project chosen, and that it demonstrates corporate alignment. Also, the PM will drive the project(s) in their lifecycle, ensuring continued alignment, adherence to budgets, forecasts, and other obligatory components to ensure a successful execution and close. The PM will also, in that same vein, continue to select and monitor the prioritization of each project and calibrate with leaders on any change management issues which arise on a given project. The PM will ensure the deliverables are crafted and the project closed in a compliant manner; also, that the outputs are still aligned to the R&D plan and operationalized (as needed), to meet the firm’s other overarching goals.
References
Bode-Greuel, K. M., Nichisch, K. J. (2008). Value-Driven Project in Portfolio Management in the
Pharmaceutical Industry: Drug Discovery Vs. Drug Development- Commonalities and
Differences in Portfolio Management Practice. Journal Of Commercial
Biotechnology, 14 (4), pp. 307-325. Retrieved from: Value-driven project and portfolio management in the pharmaceutical industry: Drug discovery versus drug development – Commonalities and differences in portfolio management practice – ProQuest
2 | Page
Sheet1
Lifecycle Pharmaceutical | Interest Rate = 5% | |||||||
Assumptions for Valuation | ||||||||
Drug Candidate | Current Stage | Complete Phase I | Complete Phase II | Complete Phase III | Drug Approval | Remaining Development Costs | ||
LC-1 | Phase II | NA | Q2 2004 | Q1 2006 | Q2 2007 | $100 MM | ||
LC-2 | Phase II | NA | Q2 2006 | Q2 2008 | Q1 2009 | $300 MM | ||
LC-3 | Phase II | Q1 2004 | Q4 2007 | Q2 2008 | Q2 2008 | $600 MM | ||
LC-4 | Preclinical | Q2 2005 | Q4 2007 | Q1 2009 | Q2 2009 | $220 MM | ||
PTC-Ph 1 | PTC-Ph 2 | PTC Ph-3 | Probability of Approval | PTC = Probability of Technical Success | ||||
LC-1 | 100% | 40% | 65% | 75% | ||||
LC-2 | 100% | 60% | 50% | 50% | ||||
LC-3 | 80% | 60% | 60% | 75% | ||||
LC-4 | 70% | 50% | 75% | 80% | Clinical Phase Durations (estimates) | |||
Phase I | 1 year | |||||||
Peak Sales | Profit Margins | Annual Expenses | Phase II | 730 days | ||||
LC-1 | $600 MM | 90% | $40 MM | Phase III | 3 years | |||
LC-2 | $800 MM | 90% | $65 MM | Drug Regulatory Submission | 0.5 year | |||
LC-3 | $1,000 MM | 80% | $80 MM | |||||
LC-4 | $750 MM | 82% | $65 MM |
Customer |
Project Name: Project Charter |
Company |
Project Name:Project Charter |
The blue-colored text passages within this document are tips and guidance for filling out |
Project: |
Project Name |
||
Title: |
Project Charter |
||
Document number: |
|||
Version |
0.1 |
||
Document status: |
Draft |
||
Author: |
Doe, John |
||
Responsible: |
|||
Date created: |
dd.mm.yy |
||
Protection class: |
“For internal use only” |
||
The Project and Author fields are filled automatically with the data from the document properties (File Properties). Once the appropriate entries have been made here, these fields can be updated with the “Update Field” function (can be found in the context menu for the individual fields).
Possible states for the document status include “Draft,” “Released,” and “Final.” The status of the current document should be specified respectively in the field above.
Document history
Version |
Date |
Author |
Comment/Change |
0.1 |
dd.mm.yy |
Draft |
|
The document history should provide an overview of the development of the document. Different versions with their date, author, and possible comments should be entered here.
Tips for Using This Template:
The Statement of Work (SOW) forms the basis for the project order. The project order represents a further level of detail. Information that is often only outlined roughly in the SOW has to be provided in greater detail in the project order. Furthermore, internal points can also often be listed in the project order, which are essential for project success.
The blue text contained in the template should provide assistance for usage. It briefly describes how the individual elements and styles are to be understood.
Please delete all of the blue text before you disseminate or print the document; it is intended exclusively for internal use.
Page
1
Background/Project purpose or justification
2.2
Scheduling goals/milestones
8
Assumptions,
restrictions
and external dependencies
9
Responsibility of the customer
B.
References, accompanying documents
1
1. Background/Project Purpose or Justification
This section describes why the project was initiated and how significant it is for the company.
2 Goals
This section describes which goals are to be realized with the project. These goals serve as a point of reference for the project closing. Measurable goals should be defined.
2.1 Goals
Goal |
Description |
2.2 Scheduling Goals/Milestones
Schedule |
Description |
3 Project Product Description
This section describes the project end product to be supplied.
Product Scope Description
The product scope description documents the characteristics of the product, service, or results that the project will be undertaken to create. The description should also document the relationship between the products, services, or results being created and the business need that the project will address.
4 Delivery Units
A list of all project products/deliverables whose complete and satisfactory delivery indicate the completion of the project.
4.1 Delivery Units/Services
Delivery Unit |
Description/Comment |
A deliverable is any unique and verifiable product, result, or capability to perform a service that is required to be produced to complete a process, phase, or project. Deliverables are typically tangible components completed to meet the project objectives and can include elements of the project management plan. Deliverables also include ancillary results, such as project management reports and documentation. These deliverables may be described at a summary level or in great detail.
5 Project Success Criteria
This section outlines the quantifiable criteria that have to be fulfilled so that the project can be performed successfully.
Project Success Criteria |
6 High-Level Risks
This section describes some of the key project risks and their potential impact on the success of the project. This list of risks should be regarded as provisional rather than complete because risks are usually identified and dealt with continuously during the course of the project.
Risk |
Possible Impacts on the Project |
7 Key Stakeholders
This section should at least contain the key stakeholders with their names and roles in the project context. This is your starting point for further stakeholder management and analysis.
Name |
Role |
8 Assumptions, Restrictions and External Dependencies
Assumptions are expectations that form the basis for decisions. This section lists the main assumptions on the basis of which appraisals, plans, and methods are defined for the project.
A |
R |
E |
Item |
A = Assumption |
R = Restriction |
E = External dependency |
9 Responsibility of the Customer
This section lists what the customer is to contribute in the course of the project. These responsibilities can be split into two categories.
9.1 Tasks
Task |
Comment |
Contact |
9.2 Resources and Staffing
Resources/Staffing |
Comment |
Contact |
10 Project Category
According to the relevant requirements and experiences in the company, the project is classified based on the following predefined features.
Project Category |
Project Categories: |
C Projects: |
B Projects: |
A Projects: |
Complexity |
Low |
Average |
High |
Risk & Impact on Company |
Low |
Average |
High |
Strategic Importance |
Low |
Average |
High |
Number of Persons on Project |
Generally 5–10 |
Generally 10–20 |
Generally > 20 |
Project Duration |
Up to six months |
6–12 months |
6–24 months |
Once the categories have been defined, please enter them above. In addition, we recommend that you mark the individual criteria in the table. The category parameters should be modified accordingly to your company/industry parameters.
11 Project Budget (Overview)
The financial framework within which the project has to operate is described here. Depending on the size of the framework, it may make sense to provide further details for individual parts.
Area |
Amount |
Project |
|
Subproject |
|
12 Project Startup
The project is deemed started with the following signatures:
Representative |
Customer |
Project Manager |
|
Signature |
|||
Name |
|||
Date |
13 Project End
Planned Project End:
13.1 Signatures for Release
The project manager is released with the signatures provided here following the project closing phase:
Representative |
Customer |
Project Manager |
|
Signature |
|||
Name |
|||
Date |
If abbreviations have been used in this document (as well as terms that need to be defined in greater detail) and common understanding for every user is a prerequisite for the success of the project, this is an opportunity to explain them.
Term |
Explanation |
II.
References, Accompanying Documents
If references have been made in this document to other external documents, these documents should be listed here.
Reference No. |
Title |
Doc. No. |
File name: Project Charter.docx Page 19 of 19
Print date 05.05.16